Quality of life in patients of chronic lymphocytic leukemia using the EORTC QLQ-C30 and QLQ-CLL17 questionnaire.
Padma YouronCharanpreet SinghNishant JindalPankaj MalhotraAlka KhadwalArihant JainGaurav PrakashNeelam VarmaSubhash VarmaDeepesh P LadPublished in: European journal of haematology (2020)
Quality of life is severely affected in CLL patients on W&W. Global health status and worries about future health and functioning were major concerns. Socioeconomic status but not age or gender impacted QoL. Patients on ibrutinib had better QoL than on CIT.